Type 1 reaction, neuritis and disability in leprosy. What is the current epidemiological situation?
- PMID: 8201838
- DOI: 10.5935/0305-7518.19940002
Type 1 reaction, neuritis and disability in leprosy. What is the current epidemiological situation?
Abstract
Type 1 reaction is one of the major causes of nerve damage in leprosy patients leading to disabilities of varying severity. Though this complication of leprosy has been extensively described, we still know very little of its natural history and of the factors which may predispose to it. This paper examines the descriptive and analytic epidemiology of these reactions in leprosy. We find that they vary greatly in clinical expression, time of onset, duration and severity, which has important implications for the way they are handled in the context of leprosy-control programmes. We review the various risk factors that have been suggested over the last 30 years and the evidence of their utility in identifying 'high-risk' patients is assessed. We then review the specific aspects of neuritis and disability in leprosy and examine the contribution of Type 1 reaction to leprosy-associated disabilities. The prospects for early detection and prevention of Type 1 reaction are examined in the light of current knowledge, both at research and at the leprosy control level.
Comment in
-
Comment: Sensory testing with nylon filaments and pens.Lepr Rev. 1995 Mar;66(1):79-80. Lepr Rev. 1995. PMID: 7731347 No abstract available.
Similar articles
-
Field evaluation of WHO-MDT of fixed duration, at ALERT, Ethiopia: the AMFES project--II. Reaction and neuritis during and after MDT in PB and MB leprosy patients.Lepr Rev. 1994 Dec;65(4):320-32. doi: 10.5935/0305-7518.19940033. Lepr Rev. 1994. PMID: 7861918
-
Impairments in multibacillary leprosy; a study from Brazil.Lepr Rev. 2004 Jun;75(2):143-52. Lepr Rev. 2004. PMID: 15282965
-
[Occurrence of neuritis among leprosy patients: survival analysis and predictive factors].Rev Soc Bras Med Trop. 2008 Sep-Oct;41(5):464-9. doi: 10.1590/s0037-86822008000500006. Rev Soc Bras Med Trop. 2008. PMID: 19009187 Portuguese.
-
[Disabilities observed in new cases of leprosy diagnosed in the Bamako district (Mali) in 1994].Acta Leprol. 1999;11(4):161-70. Acta Leprol. 1999. PMID: 10987047 Review. French.
-
A review of therapeutic nerve decompression for neuropathy in Hansen's disease with research suggestions.J Reconstr Microsurg. 2010 May;26(4):277-84. doi: 10.1055/s-0030-1248237. Epub 2010 Feb 8. J Reconstr Microsurg. 2010. PMID: 20143300 Review.
Cited by
-
High levels of inflammatory cytokines are associated with poor clinical response to steroid treatment and recurrent episodes of type 1 reactions in leprosy.Clin Exp Immunol. 2002 May;128(2):333-8. doi: 10.1046/j.1365-2249.2002.01791.x. Clin Exp Immunol. 2002. PMID: 11985524 Free PMC article.
-
Leprosy Reactions and Neuropathic Pain in Pure Neural Leprosy in a Reference Center in Rio de Janeiro - Brazil.Front Med (Lausanne). 2022 Mar 25;9:865485. doi: 10.3389/fmed.2022.865485. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35402428 Free PMC article.
-
Clinical and Histopathological Response to Multidrug Therapy in Paucibacillary Leprosy at the end of 6 Months: A Prospective Observational Study from Eastern India.Indian J Dermatol. 2018 Jan-Feb;63(1):47-52. doi: 10.4103/ijd.IJD_80_17. Indian J Dermatol. 2018. PMID: 29527025 Free PMC article.
-
Reply to Zhang et al.: The differential role of LRRK2 variants in nested leprosy phenotypes.Proc Natl Acad Sci U S A. 2020 May 12;117(19):10124-10125. doi: 10.1073/pnas.2002654117. Epub 2020 Apr 28. Proc Natl Acad Sci U S A. 2020. PMID: 32345724 Free PMC article. No abstract available.
-
Understanding the type 1 reactional state for early diagnosis and treatment: a way to avoid disability in leprosy.An Bras Dermatol. 2013 Sep-Oct;88(5):787-92. doi: 10.1590/abd1806-4841.20132004. An Bras Dermatol. 2013. PMID: 24173185 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Medical